APPH fundamentals
An in-depth look to APONTIS PHARMA AG operating, investing, and financing activities
APPH free cash flow for H2 23 is -3.47 M EUR. For 2023, APPH free cash flow was -12.27 M EUR and operating cash flow was -12.26 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM